A Phase II, Randomized, Double-blinded, Placebo-controlled, Dose-finding Clinical Study to Evaluate the Safety and Immunogenicity of Different Doses of INO-4800 Intradermal Injection Followed by Electroporation in Healthy Adult and Elderly Volunteers : COVID-19 DNA vaccine phase II clinical trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 12. Dez. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Novel Coronavirus Pneumonia (COVID-19)
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-11-22, Last updated: 2022-12-21

ICTRP ID:

ChiCTR2000040146

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007471475